Mesa Laboratories, Inc. (MLAB) Stock Forecast
MLAB analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.00 / 5 from 2 analysts
- Price target
- $125.00 average of analyst targets
- Upside to target
- +2.1% from the latest close
- Next earnings
- November 5, 2026 EPS estimate $2.24
- 52-week range
- $70.60 – $142.23
MLAB analyst ratings
2 analystsNumber of analysts at each rating.
MLAB price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
MLAB earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $2.24 | $2.24 | $2.24 | $2.11 | +6.2% | 1 |
| Next quarter (Dec '26) | $2.71 | $2.71 | $2.71 | $1.76 | +53.7% | 1 |
| Current fiscal year (FY2027) | $9.95 | $9.95 | $9.95 | $8.34 | +19.2% | 1 |
| Next fiscal year (FY2028) | $10.27 | $10.27 | $10.27 | $9.95 | +3.2% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
MLAB revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $62.2M | $60.6M | $63.8M | +2.4% | 2 |
| Next quarter (Dec '26) | $66.0M | $65.5M | $66.4M | +1.3% | 2 |
| Current fiscal year (FY2027) | $254.4M | $251.7M | $257.2M | +2.1% | 2 |
| Next fiscal year (FY2028) | $270.9M | $265.2M | $276.5M | +6.5% | 2 |
MLAB EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
MLAB revenue: reported and forecast
MLAB EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.26 | $2.73 | $2.73 | $2.73 | $2.24 | +77.8% | 0 up · 1 down |
| Next quarter (Dec '26) | $1.67 | $3.33 | $3.33 | $3.33 | $2.71 | +62.3% | 0 up · 1 down |
| Current fiscal year (FY2027) | $5.39 | $11.62 | $11.62 | $11.62 | $9.95 | +84.6% | 0 up · 1 down |
| Next fiscal year (FY2028) | $0.00 | $12.27 | $12.27 | $12.27 | $10.27 | — | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
MLAB earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; MLAB beat in 9 of 12.
What analysts expect from MLAB
2 analysts cover Mesa Laboratories; their consensus rating is buy (4.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $125.00, 2.1% above the latest close of $122.48. Analysts expect earnings of $9.95 per share for FY2027, +19.2% from a year earlier. For FY2028 the average estimate is $10.27 per share on revenue of $270.9 million. Mesa Laboratories beat the EPS estimate in 9 of the last 12 quarters.
Related: MLAB income statement, MLAB key metrics, MLAB chart. See the MLAB stock overview for the latest quote and news.
MLAB forecast FAQ
What is Mesa Laboratories's price target?
The average analyst price target for Mesa Laboratories is $125.00, 2.1% above the latest close of $122.48.
Is Mesa Laboratories a buy, hold or sell?
Of 2 analysts covering Mesa Laboratories, 1 rate it a strong buy, 0 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Mesa Laboratories's EPS forecast?
Analysts forecast $9.95 per share for FY2027 (range $9.95 to $9.95); for FY2028 the estimate is $10.27.
What is Mesa Laboratories's revenue forecast?
The average revenue estimate for FY2027 is $254.4 million, growth of 2.1%; for FY2028 it is $270.9 million.
When does Mesa Laboratories report earnings?
Mesa Laboratories is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 after the market closes; the EPS estimate is $2.24.
Does Mesa Laboratories usually beat earnings estimates?
Mesa Laboratories reported EPS at or above the analyst estimate in 9 of the last 12 quarters.